Triglyceride-glucose index impact on in-hospital mortality in acute myocardial infarction. Results from the RECUIMA multicenter registry

Martínez-García, Geovedy; Rodríguez-Ramos, Miguel Alejandro; Santos-Medina, Maikel; Mata-Cuevas, Lázaro A.; Carrero-Vázquez, Annia M.; Chipi-Rodríguez, Yanitsy

doi:10.24875/gmm.m22000646

Cited by 3 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…23,24 Prior COVID-19 studies in this country showed that this drug was administered to almost every patient. 11,17,23,24 The time to treatment was increased as well. This seems to be a widespread phenomenon, rather than a local one.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Performance Measures in STEMI after COVID-19 Pandemic: Results from the RECUIMA Registry

Espinola-Zavaleta,

Michel-Vasquez,

Santos-Medina

et al. 2023

International Journal of Cardiovascular Sciences

View full text Add to dashboard Cite

Since the first description of COVID-19 as a pandemic, in early 2020, health systems indicators of performance changed, and these were not good changes. [1][2][3] Several diseases have had their prevalence rates, their symptoms, and their intrinsic risks modified 4, 5 and heart diseases were no different. [6][7][8] During this event, a significant decline in hospitalization for cardiovascular events was observed during the government-enforced lockdowns in several countries. 9,10 In this same country, a multicentric study showed that several performance measures were under accomplished in some centers, while in others, they seemed to be over fulfilled. 11 The analysis of a particular network reported that COVID-19 has negatively impacted the care of ST-segment Elevation Acute Myocardial Infarction (STEMI) patients and care givers in low / middle income settings should continuously monitor these markers in order to detect an early variation in trends. 12

show abstract

Section: Discussionmentioning

confidence: 99%

“…Characteristics of this registry have been published earlier. 17 It is an initiative to collect data concerning patients with this entity. Among them, those data related to the direct care of these patients that allows a real-mode analysis.…”

Section: Methodsmentioning

confidence: 99%

Performance Measures in STEMI after COVID-19 Pandemic: Results from the RECUIMA Registry

Espinola-Zavaleta,

Michel-Vasquez,

Santos-Medina

et al. 2023

International Journal of Cardiovascular Sciences

View full text Add to dashboard Cite

show abstract

Value of the triglyceride–glucose index and non-traditional blood lipid parameters in predicting metabolic syndrome in women with polycystic ovary syndrome

Zhang

Wang

et al. 2023

Hormones

View full text Add to dashboard Cite

The association between triglyceride glucose-body Mass Index and in vitro fertilization outcomes in women with polycystic ovary syndrome: a cohort study

Li,

Luan,

Wei

et al. 2024

J Ovarian Res

View full text Add to dashboard Cite

Background Polycystic Ovary Syndrome (PCOS) is a common reproductive disorder that frequently affects fertility. The TyG-BMI (Triglyceride glucose-body mass) index is a newly explored parameter that may be linked to reproductive results in individuals with PCOS. Nevertheless, its connection with outcomes in In Vitro Fertilization (IVF) procedures remains uncertain. Methods This study included a total of 966 females who underwent IVF treatments for PCOS. At the baseline, the participants were categorized into four groups according to the quartiles of TyG-BMI measured prior to oocyte retrieval. Subsequently, the study compared the differences in clinical and laboratory outcomes among these four groups. Results Patients in higher TyG-BMI quartiles exhibited a decreased number of retrieved oocytes, 2PN embryos, and available/high-quality embryos (P < 0.05 for Q1-Q4). Additionally, the multivariable regression analysis revealed that individuals in the top quartile of TyG-BMI had a lower count of accessible embryos (β = -0.224, P = 0.257) and a decreased number of high-quality embryos (β = -0.352, P = 0.028) in comparison to those in the lowest quartile. Nevertheless, there were no notable variances detected in the rates of pregnancy or live births among these quartiles. Furthermore, a linear correlation was noted between the TyG-BMI index and the quantity of accessible embryos (P-non-linear = 0.6, P-overall < 0.001), along with high-quality embryos (P-nonlinear = 0.026, P-overall = 0.006). In contrast, there was no notable linear correlation found between the TyG-BMI index and the available embryo rate (P-nonlinear = 0.60, P-overall = 0.8). Conclusions The results of this research emphasize the notable correlation between TyG-BMI and IVF results in females diagnosed with PCOS. The interplay of insulin resistance and disorders of lipid metabolism may indeed play a pivotal role in influencing the assisted reproductive outcomes of patients with PCOS. Considering these findings, TyG-BMI proves to be a valuable indicator for exploring this potential association.

show abstract

Triglyceride-glucose index impact on in-hospital mortality in acute myocardial infarction. Results from the RECUIMA multicenter registry

Cited by 3 publications

References 0 publications

Performance Measures in STEMI after COVID-19 Pandemic: Results from the RECUIMA Registry

Performance Measures in STEMI after COVID-19 Pandemic: Results from the RECUIMA Registry

Value of the triglyceride–glucose index and non-traditional blood lipid parameters in predicting metabolic syndrome in women with polycystic ovary syndrome

The association between triglyceride glucose-body Mass Index and in vitro fertilization outcomes in women with polycystic ovary syndrome: a cohort study

Contact Info

Product

Resources

About